PL2118095T3 - Sposób wytwarzania zolmitriptanu - Google Patents

Sposób wytwarzania zolmitriptanu

Info

Publication number
PL2118095T3
PL2118095T3 PL08715423T PL08715423T PL2118095T3 PL 2118095 T3 PL2118095 T3 PL 2118095T3 PL 08715423 T PL08715423 T PL 08715423T PL 08715423 T PL08715423 T PL 08715423T PL 2118095 T3 PL2118095 T3 PL 2118095T3
Authority
PL
Poland
Prior art keywords
zolmitriptan
preparation
isolation
purification
optional
Prior art date
Application number
PL08715423T
Other languages
English (en)
Inventor
Monika Zatopkova
Hana Brusova
Lucie Krumbholcova
Michal Voslar
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of PL2118095T3 publication Critical patent/PL2118095T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL08715423T 2007-02-26 2008-02-25 Sposób wytwarzania zolmitriptanu PL2118095T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20070158A CZ2007158A3 (cs) 2007-02-26 2007-02-26 Zpusob prípravy zolmitriptanu
EP08715423A EP2118095B1 (en) 2007-02-26 2008-02-25 A method for the preparation of zolmitriptan
PCT/CZ2008/000022 WO2008104135A1 (en) 2007-02-26 2008-02-25 A method for the preparation of zolmitriptan

Publications (1)

Publication Number Publication Date
PL2118095T3 true PL2118095T3 (pl) 2011-04-29

Family

ID=39639367

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08715423T PL2118095T3 (pl) 2007-02-26 2008-02-25 Sposób wytwarzania zolmitriptanu

Country Status (10)

Country Link
US (1) US20100145064A1 (pl)
EP (1) EP2118095B1 (pl)
AT (1) ATE486866T1 (pl)
CZ (1) CZ2007158A3 (pl)
DE (1) DE602008003312D1 (pl)
EA (1) EA017419B1 (pl)
ES (1) ES2354590T3 (pl)
PL (1) PL2118095T3 (pl)
PT (1) PT2118095E (pl)
WO (1) WO2008104135A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE156823T1 (de) * 1990-06-07 1997-08-15 Zeneca Ltd Therapeutische heterocyclische verbindungen
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
WO2005105792A1 (en) * 2004-04-22 2005-11-10 Dr. Reddy's Laboratories Ltd. Process for preparing optically pure zolmitriptan
EP1812428A2 (en) * 2004-11-19 2007-08-01 Teva Pharmaceutical Industries Ltd Zolmitriptan crystal forms

Also Published As

Publication number Publication date
EA200901151A1 (ru) 2010-02-26
EA017419B1 (ru) 2012-12-28
CZ2007158A3 (cs) 2008-10-22
ATE486866T1 (de) 2010-11-15
EP2118095B1 (en) 2010-11-03
WO2008104135A1 (en) 2008-09-04
EP2118095A1 (en) 2009-11-18
DE602008003312D1 (de) 2010-12-16
PT2118095E (pt) 2011-01-11
ES2354590T3 (es) 2011-03-16
US20100145064A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
CL2012001348A1 (es) Sal cristalina de hemitartrato del compuesto genz-112638, inhibidor de glucosilceramida sintetasa; composición farmacéutica que la comprende;y su uso en el tratamiento de la enfermedad de gaucher y enfermedad de fabry.
MY141194A (en) Process for the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
IL183237A0 (en) Polymorphs of memantine hydrochloride
MX2012000414A (es) Derivados piridin-4-ilo.
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
WO2013040471A3 (en) Noribogaine salt ansolvates
MY150661A (en) Pyridin-3-yl derivatives as immunomodulating agents
MY156552A (en) Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
WO2012042534A3 (en) Preparation of r-sitagliptin and intermediates thereof
MY153921A (en) Aminopyrazole derivatives
UA102518C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
EP2358691B8 (en) Process for the preparation of piperazine compounds and hydrochloride salts thereof
IN2012DN04868A (pl)
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
UA99787C2 (en) Lactams as beta secretase inhibitors
MY158158A (en) Solid preparation
WO2009153461A3 (fr) Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2009126861A3 (en) Triazolopyridine compounds useful as dgat1 inhibitors
EP2033960A3 (en) Linezolid crystalline hydrate form and linezolid salts
IL183163A0 (en) Sulfonamido-macrocycles as tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
IN2012DN01292A (pl)
WO2011047530A8 (zh) 类胡萝卜素衍生物及其制备方法和应用
MX2010004505A (es) Piperidinas 4,4-disustituidas.
MX2010004235A (es) Piperidinas tri-sustituidas.
PL2118095T3 (pl) Sposób wytwarzania zolmitriptanu